Episódios
-
After highlighting a case of a 31-year old with RV failure, the faculty discuss options, considerations, and barriers based on three settings: the community hospital, the hybrid hospital, and the quaternary care center.
-
Estão a faltar episódios?
-
With support from our colleagues at Thrombolex, learn more about how to incorporate pharmaco-mechanical thrombolysis into your practice
-
Listen to highlights for transferring patients with acute PE
-
Our faculty perform a mock PERT call with an intermediate high risk PE patient.
-
Join expert faculty as they describe the ins and outs of starting a PERT program
-
Learn more about how artificial intelligence may improve PE care
-
Hear firsthand from leaders of the Interhospital Transfer Project Dr. Charles Ross, Dr. Michael McDaniel, Dr. Belinda Rivera-Lebron, and Dr. Parth Rali who recap some of the key take aways from studying interhospital transfers of PE patients from across the country.
-
The Course Directors of The PERT Consortium’s 2021 Annual Scientific Symposium summarize some key take aways from the event.
-
The session features Dr. John Moriarty, Dr. Jaafar Golzar, and Dr. Brent Keeling who provide an overview of the AlphaVac System and provide an introduction to the APEX-AV study.
-
In this edition of PERTCast, Dr. Lindsay Lief, Professor Fionnuala Ní Áinle, and Professor Beverley Hunt recap important parts of the webinar: sex-specific differences in men and women as it relates to PE-specific events, anticoagulation in women with menstrual periods, and PE diagnosis and treatment during pregnancy.
-
Join Dr. Frances Mae West, Dr. Charles Grodzin, Dr. Emily Gundert, Dr. Jim Horowitz, & Dr. Alison Witkin as they recap mechanical measures to achieve hemodynamic stability, including ecmo and right ventricular support.
-
Dr. Jim Horowitz follows up with our speakers Dr. Brent Keeling, Dr. Rich Channick, Dr. Hillary Johnson-Cox, Dr. Sameer Khandar, and Dr. Akhilesh Sista to recap thoughts on burning questions like is clot burden associated with PE severity? Is increased clot removal associated with improved outcomes? Does increased retained clot lead to worsening long-term quality of life or outcomes?
-
Join us for this PERTcast featuring Dr. Ken Rosenfield, MD co-principal investigator in the latest clinical trial to date, Hi PEITHO. We meet the co-PI and ask clinical questions, trial endpoints, and study design for this new trial. Its a landmark venture you don’t want to miss out on.
-
The PERT consortium invites you to listen to a podcast moderated by Geoff Barnes, MD, and joined by Rachel Rosovsky, MD, and Scott Kaatz, DO, as they discuss extended VTE treatment and the American Society of Hematology (ASH) 2020 guidelines.
These podcasts were developed by the featured Pulmonary Embolism Response Team (PERT) Consortium speakers through a sponsorship from Janssen Pharmaceuticals, Inc. Doctors are also paid consultants of Janssen Pharmaceuticals, Inc.
© Janssen Pharmaceuticals, Inc. June 2021 cp-173153v3
- Mostrar mais